You are here

  • Home
  • Archive
  • Volume 12, Issue 11
  • Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study

Article metrics

Article menu

Download PDFPDF

XML
Hemorrhagic Stroke
Original research
Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study

 

Online download statistics by month:

Online download statistics by month: June 2020 to September 2024

AbstractFullPdf
Jun 2020850835453
Jul 202024823790
Aug 2020716936
Sep 2020898552
Oct 202018918663
Nov 202011110263
Dec 2020918837
Jan 2021747134
Feb 2021898438
Mar 2021989157
Apr 2021472466109
May 202119619062
Jun 202115014463
Jul 20219897101
Aug 202112712185
Sep 202111811374
Oct 202111410983
Nov 20211039894
Dec 20217610356
Jan 2022938745
Feb 2022898645
Mar 202210510352
Apr 2022888485
May 202211210946
Jun 2022969039
Jul 2022757327
Aug 2022969453
Sep 202210410338
Oct 202215715430
Nov 202211410950
Dec 2022797732
Jan 202311010632
Feb 202310810128
Mar 2023788034
Apr 2023969135
May 2023838029
Jun 202312912539
Jul 202310810534
Aug 20231089815
Sep 2023827818
Oct 2023706629
Nov 202310110822
Dec 2023908820
Jan 2024474241
Feb 2024868427
Mar 2024857829
Apr 2024737231
May 202423222638
Jun 2024928914
Jul 202415615741
Aug 2024565525
Sep 2024948933
Total665664762806